The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 4 , Pages 986-994.e2, April 2007

Acute in vivo evaluation of a new stentless mitral valve

  • Jose L. Navia, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
    • Corresponding Author InformationAddress for reprints: Jose L. Navia, MD, Department of Thoracic and Cardiovascular Surgery/F24, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195.
  • ,
  • Kazuyoshi Doi, MD

      Affiliations

    • Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Fernando A. Atik, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Kiyotaka Fukamachi, MD, PhD

      Affiliations

    • Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Michael W. Kopcak Jr, BA

      Affiliations

    • Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Raymond Dessoffy, AA

      Affiliations

    • Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Pablo Ruda-Vega, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Mario Garcia, MD

      Affiliations

    • Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Penny L. Houghtaling, MS

      Affiliations

    • Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
  • ,
  • Maureen Martin, RDCS

      Affiliations

    • Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Eugene H. Blackstone, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
    • Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
  • ,
  • Patrick M. McCarthy, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio
  • ,
  • Bruce W. Lytle, MD

      Affiliations

    • Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland, Ohio

Received 7 February 2006; received in revised form 8 November 2006; accepted 20 November 2006.

Objectives

We have developed a stentless pericardial mitral valve prosthesis in 2 configurations; the purposes of this acute study in sheep were to assess (1) valve design and implant technique; (2) valve performance; and (3) acute effects on postimplant left ventricular function.

Methods

A stentless bovine pericardial bileaflet valve was developed with the intent to preserve annular–papillary muscle continuity. This valve, in 2 configurations—with (n = 5) and without (n = 5) flap chordae—was implanted in 10 sheep (mean weight 73 ± 9 kg). Epicardial echocardiography was performed to assess valve performance. Load-independent left ventricular function was also estimated before implantation (baseline), 1 hour after discontinuing cardiopulmonary bypass (rest), and during dobutamine stimulation using conductance technology.

Results

Implantation was easily accomplished for both configurations. Both configurations had low transvalvular pressure (mean 2.1 ± 1.2 mm Hg at rest; 2.2 ± 1.0 mm Hg with dobutamine stimulation with flap chordae; 1.7 ± 0.5 mm Hg and 1.6 ± 0.3 mm Hg without flap chordae). No mitral regurgitation was observed in 8 sheep, and mild regurgitation was seen in 2 sheep. Compared with baseline, slope of maximum rate of change of left ventricular pressure–end-diastolic volume relation increased with stimulation both with flap chordae (+52 ± 41 mm Hg · s−1 · mL−1, P = .0005) and without (+20 ± 12 mm Hg · s−1 · mL−1, P = .003).

Conclusions

Both configurations of this newly designed stentless mitral bioprosthesis, which preserves annular–papillary muscle continuity using different novel surgical implantation techniques, demonstrated reliable valve performance, with low transvalvular pressure gradients, minimal regurgitation, and acutely preserved postimplant left ventricular function. Further chronic study is needed to verify these results and evaluate reliability of implantation procedures, biocompatibility, and durability.

CTSNet classification: 35

Abbreviations and Acronyms: CPB, cardiopulmonary bypass, F-SMV, stentless mitral valve with flap chordae, LV, left ventricular, SMV, stentless mitral valve

 

PII: S0022-5223(06)02367-1

doi:10.1016/j.jtcvs.2006.11.044

Refers to article:

  • Stentless mitral valves

    Robert W.M. Frater
    The Journal of Thoracic and Cardiovascular Surgery April 2007 (Vol. 133, Issue 4, Pages 861-864)

The Journal of Thoracic and Cardiovascular Surgery
Volume 133, Issue 4 , Pages 986-994.e2, April 2007